CoreMap

Burlington, MA · Founded 2016 · Privately Held (backing)

Developer of a diagnostic technology designed to enable curative treatment options. CoreMap is based in Burlington, MA and was founded in 2016. Its last reported valuation was $67.3 million in Feb 2022. It has raised $44.1 million across 3 recorded rounds; the latest was a $35.5 million early-stage round in Jun 2026.

Last reported valuation
$67.3M
Oct 2026
Priced at
—
Total raised
$44.1M
Last round
Early Stage VC
Jun 2026

Who backs CoreMap?

12 investors
InvestorType
US National Science FoundationOther
Northpoint Capital GroupPE / buyout
DRIVEN Accelerator Hub—
Dudley Fund—
Hula—
MassMEDIC—
Minnow Ventures—
P5 Health Ventures—
Philips—
Qure Ventures—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

CoreMap investors

12 investors are on record for CoreMap, including US National Science Foundation, Northpoint Capital Group, DRIVEN Accelerator Hub and Dudley Fund. The early-stage round in Jun 2026 drew 73 investors.

Free account
More of CoreMap with a free account
  • ·The complete investor list: 12 names
  • ·Watch CoreMap: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like CoreMap. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View